Part 1 | Testing for SARS-CoV-2 Antibodies: How it began

Assessment of the Humoral Response to SARS-CoV-2 Infection Via Novel Multiplexed Assays
Guest speaker: Dr. Howard Gebel of Emory University in Atlanta, Georgia

Development for SARS-CoV-2 antibody detections tests has accelerated at an astounding pace, but many tests don’t identify the variety of antibodies that can arise in response to the virus. Dr. Howard Gebel with Emory University Hospital shares a presentation on why he and his colleagues became interested in developing a new assay that would be comprehensive, specific, and sensitive enough to build a complete antibody profile for patients exposed to the COVID-19 virus.